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The relative contribution of target-
site mutations in complex acaricide 
resistant phenotypes as assessed 
by marker assisted backcrossing in 
Tetranychus urticae
Maria Riga1,2, Sabina Bajda3, Christos Themistokleous1, Stavrini Papadaki1, Maria Palzewicz3, 
Wannes Dermauw  4, John Vontas2,5 & Thomas Van Leeuwen3,4
The mechanisms underlying insecticide and acaricide resistance in insects and mites are often complex, 
including additive effects of target-site insensitivity, increased metabolism and transport. The 
extent to which target-site resistance mutations contribute to the resistance phenotype is, however, 
not well studied. Here, we used marker-assisted backcrossing to create 30 congenic lines carrying 
nine mutations (alone, or in combination in a few cases) associated with resistance to avermectins, 
pyrethroids, mite growth inhibitors and mitochondrial complex III inhibitors (QoI) in a polyphagous 
arthropod pest, the spider mite Tetranychus urticae. Toxicity tests revealed that mutations in the 
voltage-gated sodium channel, chitin synthase 1 and cytochrome b confer high levels of resistance and, 
when fixed in a population, these mutations alone can result in field failure of acaricide treatment. In 
contrast, although we confirmed the implication of mutations in glutamate-gated chloride channels 
in abamectin and milbemectin insensitivity, these mutations do not lead to the high resistance levels 
that are often reported in abamectin resistant strains of T. urticae. Overall, this study functionally 
validates reported target-site resistance mutations in T. urticae, by uncoupling them from additional 
mechanisms, allowing to finally investigate the strength of the conferred phenotype in vivo.
Insecticide resistance is a major threat for the chemical control of insects and mites in public health and agricul-
ture. At present, the Insecticide Resistance Action Committee (IRAC) distinguishes between at least fifty-five 
different chemical classes and more than twenty-five distinct mode of action (MoA) groups1. MoA diversity is 
of key importance for effective Insecticide Resistance Management (IRM). However, the costs involved in the 
discovery, development and marketing of chemicals with new properties, increased immensely and slow down 
the development of compounds with new MoA. In addition, concerns about the environment and human health, 
integrated in new regulations, demand molecules with better selectivity2. To preserve the utility and diversity of 
available and newly developed insecticides/acaricides, it is of utmost importance to understand the resistance 
mechanisms against these compounds1 and develop diagnostic tools that support monitoring activities and resist-
ance management.
A number of mechanisms have been shown to underlie insecticide resistance, most often quantitative or 
qualitative changes in major detoxification enzymes and transporters (pharmacokinetic mechanisms) and/or 
target-site mutations (pharmacodynamic mechanisms)3–5. When resistance is caused by a combination of factors 
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(polygenic resistance), the overall resistance levels may be the sum of contribution of each individual factor6, 7 but 
synergistic or antagonistic interactions between resistance loci also occur8–10. The relative contribution of each 
individual resistance locus to complex insecticide/acaricide resistance phenotypes has only been sporadically 
investigated11. In particular, the relative importance and strength of target-site mutations is often hard to assess 
by merely associating a phenotype with mutation frequency in field populations, where prolonged selection may 
have led to the accumulation of additional resistance mechanisms. Furthermore, the majority of studies that look 
into epistatic interactions and/or resistance levels confirmed by a single genetic factor, are sometimes difficult to 
interpret if resistance alleles are not investigated in a common genetic background9, 12–15. Therefore, analysis of 
a resistance trait requires the studied strains to be identical, except for its causal gene16, 17. Functional validation 
of resistance mutations has been reported after recombinant expression. Inhibitor-protein interactions are then 
quantified via enzymatic reactions or ligand binding assays such as voltage-clamp electrophysiology. Although 
they provide strong evidence of the effect of a mutation on the affinity for the compound to the target-site, they 
are less suitable to assess the relative phenotypic consequences in vivo18, 19. A more precise way to determine the 
effect of a mutation in vivo is to introduce it in a defined susceptible genetic background, by utilizing genome edit-
ing techniques, such as CRISPR-Cas920, 21, in species where this approach is applicable. In species where genome 
editing tools are not yet available, a more feasible alternative is to repeatedly backcross resistant individuals with 
susceptible ones16, 22, 23. Marker-assisted backcrossing provides a straight-forward and relatively precise method to 
untangle a mutation of interest from other mechanisms that might have been co-selected. The impact of a mod-
ifier or interactions between modifiers can be then analyzed by comparing the genetically identical strains that 
differ only in a small region on the chromosome, which harbors the resistant locus of interest24, 25.
The two-spotted spider mite, Tetranychus urticae (Chelicerata: Acari: Acariformes) is an important agricul-
tural pest, that thrives on more than a 1,000 plant species26, 27. Its short life cycle, high fecundity and haplo-diploid 
system facilitates a rapid evolution of acaricide resistance. Today, T. urticae has developed resistance to more 
than 90 different chemical compounds, including major groups of currently used acaricides1, 28, 29. In T. urticae 
and other related spider mites, very high resistance ratios (RRs) have been reported for a number of compounds 
(RR > 10,000)28, 30 with cases of cross-resistance to newly introduced acaricides, for example, Khalighi, et al.31. 
Several target-site mutations have been uncovered and were associated with acaricide resistance in populations 
of T. urticae, recently summarized in Van Leeuwen and Dermauw4. These include mutations leading to amino 
acid substitutions in acetylcholinesterase (AChE) (G119S, A201S, T280A, G328A and F331W) that are associated 
with resistance to organophosphates and carbamates32. The L1024V and A1215D + F1538I substitutions in the 
voltage-gated sodium channel (VGSC) have been linked to resistance to Type I (absence of α-cyano group) and 
Type II (presence of α-cyano group) pyrethroids33, 34. Six orthologous glutamate–gated chloride channel (GluCl) 
genes have been reported in spider mites and the substitutions G314D and G326E in GluCl1 and GluCl3, respec-
tively, were associated with resistance to abamectin35, 36. The G126S, I136T, S141F, D161G, P262T substitutions (in 
different combinations) identified in the cytochrome b (cytb) cause strong bifenazate resistance (Mitochondrial 
Qo inhibitors: QoI)37. A substitution I1017F in the chitin synthase 1 gene (CHS1) has been linked with high lev-
els of resistance to mite growth inhibitors, etoxazole, clofentezine and hexythiazox38, 39. Most recently, an H92R 
substitution in the PSST subunit of the Mitochondrial Respiratory Complex I, has been associated with resistance 
to pyridaben, tebufenpyrad and fenpyroximate (Mitochondrial Electron Transport Inhibitors, site I, METI-I)25. 
As resistance in spider mites often has a polygenic basis, the relative contribution of target-site resistance to the 
overall resistance levels is currently unknown. One notable exception for T. urticae is the H92R mutation in the 
PSST subunit, which was introduced into a susceptible background by repeated backcrossing and shown to confer 
moderate levels of METI resistance25.
In this study, we investigated the relative contribution of nine known target-site mutations conferring resist-
ance to abamectin, pyrethroids, bifenazate and mite growth inhibitors. We adopted the method of Bajda, et al.25 
and succeeded in generating 30 congenic resistant and susceptible lines of T. urticae. When a combination of 
mutations in homologous genes was reported, the phenotypic levels of resistance were examined for both the 
single mutations, as well as their combination.
Materials and Methods
Acaricides. Acaricides used in this study were commercial formulations of bifenazate (Floramite, 240 g l−1 
SC) and acequinocyl (Cantack 164 g l−1 SC), etoxazole (Borneo, 120 g l−1 SC), hexythiazox (Nissorun, 250 g l−1 
SC) and clofentezine (Apollo, 500 g l−1 SC), abamectin (Vertimec 18 g l−1 EC), milbemectin (Milbeknock 10 g l−1 
EC), bifenthrin (Talstar 100 g l−1 EC), fluvalinate (Mavrik 240 g l−1 EW) and analytical grade fenpropathrin 
(Sigma Aldrich).
Spider mite strains. The susceptible Wasatch strain is an inbred line, originally collected from tomato in 
a greenhouse near Salt Lake City, Utah, USA. The pyrethroid susceptible strain KOP8 is an inbred line derived 
from the Houten strain40. Wasatch does not contain any of the so far described mutations. KOP8 harbors the 
A1215D substitution, potentially associated with pyrethroid resistance. The GH strain carries the L1024V geno-
type (Musca domestica numbering) of the VGSC gene and was collected from greenhouse grown maize in Utah 
USA. The TuSB9 strain carrying the A1215D and F1538I mutations (Musca domestica numbering) in VGSC was 
previously described33. The MAR-AB strain carrying the G314D and G326E substitutions (Tetranychus urticae 
numbering) in GluCl1 and GluCl3, respectively, was previously described in Dermauw, et al.35. Strains with muta-
tions associated with bifenazate resistance, HOL3 (cytb, P262T - Tetranychus urticae numbering) and BR-VL 
(cytb, G126S and S141F – Tetranychus urticae numbering) were described in Van Leeuwen, et al.37 and Van 
Leeuwen, et al.41 respectively. The EtoxR strain carrying the I1017F mutation (Tetranychus urticae numbering) in 
the chitin synthase (CHS1) gene was previously described38. An overview of strains is presented in Table 1. All T. 
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urticae strains were maintained on 3-week old potted kidney bean plants (Phaseolus vulgaris L.) in a climatically 
controlled room or incubator at 25 ± 1 °C, 60% relative humidity, and 16:8 light: dark photoperiod.
Backcrossing experiments. To assess the relative resistance levels associated with mutations, we used a 
marker assisted backcrossing approach to produce near-isogenic sister lines (Fig. 1 and Table 1). The crossing 
procedure was previously outlined in Bajda, et al.25. In short, a haploid male of the resistant strain was crossed 
with a virgin female of the susceptible strain. The resulting heterozygous virgin females were backcrossed to sus-
ceptible males and heterozygote genotypes were identified by a TaqMan molecular assay or PCR and sequencing 
as it is described in section Genotyping. This process was repeated for six to nine generations. In the last gen-
eration, a cross was carried out between the backcrossed heterozygous virgin females and their first born sons 
representing either a susceptible (absence of mutation) or the resistant (presence of mutation) genotype. This 
finally resulted in congenic homozygous lines for the mutation and the wild type allele. The final crosses were per-
formed as follows (see Table 1): For the mutations in GluCls, G314D in GluCl1 and G326E in GluCl3, MAR-AB 
males were crossed with Wasatch virgin females in order to separate the mutations in different lines, as they are 
inherited independently35, after which they were introgressed separately: ♀ 314D/314 G x ♂ 314D or ♂ 314 G to 
generate GluCl1_R1-R3 and GluCl1_C, ♀326E /326 G x ♂ 326E or ♂326 G to produce homozygous congenic 
GluCl3_R1-R3 and GluCl3_C respectively. Mutations were later joined in a single line by dedicated crosses as 
follows: ♀GluCl1_R1 x ♂GluCl3_R1, ♀GluCl1_R2 x ♂GluCl3_R2, ♀GluCl1_R3 x ♂GluCl3_R3 and ♀GluCl1_C x 
♂GluCl3_C to produce GluCl1 + 3_R1,R2,R3 and C respectively. For the mutations in VGSC; the ♀1024 V/1024 L 
x ♂1024 V or ♂1024 L were crossed to obtain homozygous congenic lines VGSC_R1-R3 and VGSC_C1 respec-
tively, ♀1215D + 1538I/1215D + 1538 F x ♂1215D + 1538I or ♂1215D + 1538 F to obtain homozygous congenic 
VGSC_R4-R6 and VGSC_C2 respectively. For the mutation in CHS1; ♀ 1017 F/1017I x ♂ 1017 F or ♂1017I were 
crossed to generate homozygous congenic CHS1_R1-R3 and CHS1_C, respectively.
For the mitochondrial mutations in cytb (HOL3 and BR-VL) that are inherited completely maternally, simple 
crosses between resistant females and susceptible males were performed for 7 generations, as to create a line 
with the nuclear genome of the susceptible parent (Wasatch), but bearing the mitochondrial haplotype of the 
resistant line (Fig. 1). Three crosses were set up to produce lines carrying P262T mutation in PEWY motif of cytb 
(cytb_R1-R3) and consequently three lines with G126S + S141F mutations in cd1 region of cytb (cytb_R4-R6).
Single mite DNA extraction. In order to perform single mite genotyping for I1017F (EtoxR), P262T 
(HOL3) and G126S + S141F (BR-VL) individual T. urticae mites were homogenized in 20 μl STE buffer (100 mM 
NaCl, 10 mM Tris- HCl and 1 mM EDTA) with 1 mg ml−1 proteinase K (Sigma-Aldrich). Homogenate was incu-
bated at 37 °C for 30 min followed proteinase K inactivation for 5 min at 95 °C. For G314D, G326E (MAR-AB) 
and F1538I, A1215D (TuSB9), L1024V (GH) single mite DNA was extracted following the CTAB method42. 
In short, individual mites were homogenized in 200 μl of extraction buffer (2% CTAB, 1.4 M NaCl, 0.2% 
β-mercaptoethanol, 20 mM EDTA, 100 mM Tris – HCl, pH:8.0) and incubated at 65 °C for 15 min. Equal volume 
of chloroform: isoamylalcohol (24:1) was used in order to remove proteins. The DNA was precipitated by iso-
propanol and washed with 75% ethanol. The pellet was air-dried and resuspended in 20 μl DEPC treated water.
Genotyping. Single mite genotyping was performed with standard PCR and sequencing (mutations I1017F, 
P262T, G126S + S141F and L1024V) and/or TaqMan method43 (mutations F1538I, G314D and G326E). PCRs 
were conducted in 50 μl final volume with 10 μl 5x Phusion HF Buffer, 0.2 mM of each dNTP, 0.5 μM each 
primer, 1 μl template, 0,5 μl polymerase with cycling conditions; 30 s at 98 °C followed by 35 cycles 5 s at 98 °C, 
10 s at 55 °C, 15 s at 72 °C and 5 min of final extension. Reactions were performed in Bio-Rad T100™ Thermal 
Cycler. PCR products were purified with E.Z.N.A.® Cycle Pure Kit DNA purification kit (OMEGA bio-tek) and 
strain resistant to* target-sitemutation crossed to backcrossed lines
MAR-AB abamectin (6)3 GluCl1 (G314D) Wasatch
GluCl1_C, 
GluCl1_R1, 
R2, R3 GluCl1 + 3_C, 
GluCl1 + 3_R1, 
R2, R3
MAR-AB abamectin (6)3 GluCl3 (G326E) Wasatch
GluCl3_C, 
GluCl3_R1, 
R2, R3
GH pyrethroids (3 A)3 VGSC (L1024V) Wasatch VGSC _C1, VGSC _R1, R2, R3
TuSB9 pyrethroids (3 A)3 VGSC (F1538I + A1215D) KOP8 VGSC_C2, VGSC_R4, R5
HOL3 bifenazate (20 A)3 cytochrome b (P262T) Wasatch cytb_R1, R2, R3
BR-VL bifenazate (20 A)
3 
acequinocyl (20B)3
cytochrome b 
(G126S + S141F) Wasatch cytb_R4, R5
EtoxR mite growth inhibitors (10)1,2
chitin synthase 
(I1017F) Wasatch CHS1_C, CHS1_R1, R2, R3
Table 1. Summary of crosses performed to create congenic T. urticae lines. VGSC mutations were numbered 
according to Musca domestica numbering, whereas GluCl1, GluCl3, cytochrome b and chitin synthase 
substitutions according to Tetranychus urticae numbering. *IRAC mode of action group number is shown 
between brackets. Superscript numbers indicate which mite stage was used in the toxicity assay (1: larval 
toxicity assay, 2: egg toxicity assay, 3: adult toxicity assay). Refer to section Toxicity bioassays for more details.
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sequenced at Macrogen sequencing facility (Amsterdam). Sequencing data were analyzed using BioEdit 7.0.1 
software44. Primers used for the PCR reactions and sequencing are listed in Supplementary Table S1.
TaqMan assay was performed as previously described43. In short, all assays were carried out in 15 μl total volume 
containing 2 μl of genomic DNA, 7.5 μl TaqMan Universal PCR Master Mix, 0.8 μM of each primer and 0.2 μM of each 
probe. Samples were run on CFX Connect, Real-Time PCR Detection System (Biorad) using the temperature cycling 
conditions of: 10 min at 95 °C followed by 40 cycles of 92 °C for 15 sec and 60 °C for 1 min. The increase in VIC and FAM 
reporter dyes, representing individuals with the resistant and susceptible alleles respectively, was monitored in real time 
using the CFX Manager software. Positive and negative template controls were included in each run to aid genotype 
scoring. Primers and probes used for the TaqMan assay are listed in Supplementary Table S1.
Toxicity bioassays. To assess the toxic effects of etoxazole and hexythiazox, larval bioassays (1) were per-
formed as previously described by Van Pottelberge, et al.45. For the ovicide clofentezine, bioassays were performed 
on eggs (2) instead of larvae. Approximately fifty females were allowed to lay eggs for 5 hours on the upper side 
of 9 cm2 square-cut kidney bean leaf discs on wet cotton wool. For adulticidal bioassays (3)46, 20–30 young adult 
female mites were transferred to arenas, prepared as described above. Plates were sprayed with 1 ml of spray 
fluid at 1 bar pressure with a Potter Spray Tower (Burkard Scientific, UK) to obtain a homogenous spray film 
x
x
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TaqMan assay
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x x
1:2
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Figure 1. Schematic diagram of marker-assisted backcrossing of nuclear and mitochondrial encoded resistance 
mutations. The susceptible genotype is depicted by white-colored chromosomes (rectangles) and mitochondria 
(ovals), while those of the resistant genotype are depicted in blue. An orange color indicates whether the 
resistance mutation is either nuclear or mitochondrial encoded.
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(2 mg deposit/cm2). Experiments were then placed in a climatically controlled room at 25 ± 0.5 °C, 60% RH and 
16/8 h (light/dark) photoperiod. Three to four replicates of at least five serial dilutions of each acaricide and a con-
trol (deionized water or 1:100 dilution of the mixture of N, N-dimethylformamide and emulsifier W, depending 
on the acaricide used) were tested. Fenpropathrin was of technical grade and formulated in 3:1 v/v mixture of N, 
N-dimethylformamide and emusulfier W and subsequently diluted in deionized water as previously described47. 
Mortality was assessed after 24 h for bifenazate and acequinocyl and 48 h for all other acaricides. Mites treated 
with growth inhibitors, were considered as unaffected, if at the time of scoring displayed the same developmental 
stage as water treated control. Adult mites were scored as being alive if they could walk twice the distance of their 
body size after being prodded with a camel’s hair brush48. All mortalities obtained for control treatment were 
lower than 10%. LC50 values, slopes, RRs and 95% confidence limits were calculated by probit analysis (POLO, 
LeOra Software, Berkeley, USA)49. In case 5,000 mg l−1 did not cause 50% mortality, no further attempts were 
made to determine LC50s and RR was calculated by dividing 5,000 mg l−1 by the LC50 of susceptible strain. The 
effect of the treatment on the susceptible parent and the experimental line was considered significantly different if 
the hypothesis of equality of slopes and intercepts was rejected (p value = 0.05)50. If a regression line - illustrating 
dose response - could not be derived (LC50 of the experimental line was found to be higher than 5,000 mg l−1), the 
effect of treatment was considered different when the LC90 of the susceptible control was lower than 5,000 mg l−1.
Data availability. All data generated or analyzed during this study are included in this manuscript (and its 
Supplementary Information Files).
Results
Establishment of congenic lines. The initial crosses between parental resistant and susceptible strains 
are outlined in Table 1. Briefly, the susceptible strain Wasatch, which does not carry any of the mutations studied 
here, was used for the most of the backcrossing experiments (Table 1). To study the mutations in GluCl1 (G314D) 
and GluCl3 (G326E) associated with abamectin resistance, virgin females of Wasatch were crossed with males 
of the abamectin resistant strain MAR-AB carrying both GluCl mutations. Similarly, for the L1024V mutation 
associated with pyrethroid resistance, Wasatch virgin females were crossed with males of the pyrethroid resistant 
strain GH that carries L1024V. The effect of A1215D + F1538I mutations in pyrethroid resistance was examined 
through crossing males of TuSB9 with females of the parental susceptible strain KOP8 (carrying the A1215D 
only). To study the effect of mutations in the mitochondrial encoded cytb (P262T and G126S + S141F) that confer 
resistance to bifenazate, virgin females of bifenazate resistant strains HOL3 (P262T) and BR-VL (G126S + S141F), 
were crossed to males of Wasatch. Last, to introduce the mutation I1017F associated with resistance to mite 
growth inhibitors, virgin females of Wasatch were crossed with EtoxR males (Table 1).
For the nuclear encoded mutations, the final cross between heterozygous backcrossed females and their sons 
resulted in congenic homozygous lines with either the mutation fixed or absent (Fig. 1, Table 1, see Backcrossing 
experiments paragraph for outline of experimental setup). Since mutations in GluCl1 and GluCl3 are not geneti-
cally linked35, the impact of each mutation could be assessed separately. Once homozygous backcrossed lines car-
rying a mutation either in GluCl1 (GluCl1_R1-R3) or in GluCl3 (GluCl3_R1-R3) and their respective congenic 
control lines (GluCl1_C and GluCl3_C) were generated, the mutations were joined again by dedicated crosses, 
giving rise to GluCl1 + 3_R1-R3. The susceptible control GluCl1 + 3_C was obtained with the cross GluCl1_C x 
GluCl3_C. One replicate with genotype A1215D + F1538I (pyrethroid resistance mutations) and one with gen-
otype G126S + S141F (bifenazate resistance mutations) were lost during backcrossing and only two biological 
replicates VGSC_R4, R5 and cytb_R4 and R5 could be analyzed for each genotype.
Toxicity assays. Parental strains. Abamectin and milbemectin were tested against the parental susceptible 
strain, Wasatch and the resistant strain, MAR-AB (G314D + G326E), with the latter one exhibiting high resist-
ance levels to abamectin (1,354.9 fold) and moderate resistance to milbemectin (71.7 fold) in comparison to 
Wasatch (Supplementary Table S2).
The parental susceptible strains, KOP8, which carries only the A1215D VGSC substitution, and Wasatch 
showed high susceptibility to bifenthrin, fluvalinate and fenpropathrin whereas the GH (L1024V) and TuSB9 
(A1215D + F1538I) resistant strains were highly resistant to the aforementioned pyrethroids (Table 2).
The Wasatch strain and the parental resistant strains HOL3 (P262T) and BR-VL (G126S + S141F) were tested 
against bifenazate. The resistant strains exceeded 2,000 fold of resistance to bifenazate. Additionally, the parental 
susceptible strain and BR-VL were treated with acequinocyl, with the latter one showing moderate levels of resist-
ance (RR of 28.9 fold) (Fig. 2, Supplementary Table S3).
Etoxazole, clofentezine and hexythiazox were tested against the EtoxR strain (I1017F) and the susceptible strain 
Wasatch. The EtoxR strain showed extremely high levels of insensitivity to all three compounds used, with RR values 
exceeding 40,000 for etoxazole, 4,000 for hexythiazox and 2,000 for clofentezine (Supplementary Table S4, Fig. 3).
Backcrossed strains. Abamectin and Milbemectin. The introgressed strains carrying resistance mutation in only 
one of the GluCls (either GluCl1 or GluCl3) showed minor resistance to abamectin and milbemectin with RR val-
ues up to 3.3 and 1.6 folds, respectively (Fig. 4, Supplementary Table S2). However, when mutations were joined 
by dedicated crosses, individuals carrying both mutations (GluCl1 + 3_R1-3 congenic lines) showed higher 
resistance levels to both compounds. The RR values obtained for abamectin and milbemectin were up to 19.8 and 
13.7 fold, respectively (Fig. 4, Supplementary Table S2).
Pyrethroids. The backcrossed strains VGSC_R1-3 and VGSC_R4,5 exhibited high levels of resistance to all 
pyrethroids used in this study (bifenthrin, fluvalinate and fenpropathrin), with RR values being greater than 200 
fold in some cases. In contrast, the backcrossed susceptible lines VGSC_C1 and VGSC_C2 were susceptible to all 
three compounds (Table 2).
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Mitochondrial QoI. The backcrossed strains cytb_R1, R2 and R3 carrying the P262T mutation in cytb 
sequence showed high resistance levels to bifenazate (Fig. 2, Supplementary Table S3). Interestingly, the com-
bination of cytb substitutions; G126S and S141F provided higher level of resistance to bifenazate compared to 
P262T, since RRs for both cytb_R4 and R5 were higher than 2,000 fold. The importance of G126S and S141F in 
the observed levels of cross-resistance to acequinocyl in BR-VL was confirmed (Fig. 2, Supplementary Table S3).
Mite growth inhibitors. The backcrossed strains homozygous for I1017F mutation displayed extreme levels 
of resistance to all three mite growth inhibitors tested (Fig. 3, Supplementary Table S4). RRs estimated for etox-
azole, hexythiazox and clofentezine exceeded 40,000, 4,000 and 2,000 fold, respectively (Fig. 3, Supplementary 
Table S4). In contrast, the backcrossed control line was highly susceptible to the aforementioned compounds 
(Fig. 3, Supplementary Table S4).
Discussion
Field collected T. urticae strains often exhibit very high levels of resistance to multiple acaricides used for their 
control. Due to the identification of acaricide target-site sequences29, 51 and implementation of recently devel-
oped genetic mapping tools4, 25, 38, a number of mutations has been uncovered in the target-site of frequently 
Compound Strain Genotype Na LC50 mg l−1 (95% CI) Slope ( ± SE) χ2 (df) RR (95% CI)b
bifenthrin
Wasatch L1024 404 3.8 (2.1; 4.7) 3.9 (±0.8) 17 (13) —
GH L1024V 443 1,031.0 (721.7; 1,406.8)a 1.5 (±0.1) 14 (13)
271.8 (185.3; 
398.8)
KOP8 A1215D + F1538 354 4.1 (3.0; 4.8) 3.2 (±0.6) 8 (16) —
TuSB9 A1215D + F1538I 517 1,715.8 (696.5; 2,474.8)a 2.3 (±0.4) 24 (16)
423.5 (272.4; 
658.4)
VGSC_C1 L1024 382 5.09 (3.4; 6.2)a 4.9 (±0.8) 26 (13) 1.3 (1.0; 1.8)
VGSC_C2 A1215D + F1538 436 4.6 (3.3; 5.5) 4.8 (±0.8) 29 (16) 1.1 (0.9; 1.5)
VGSC_R1 L1024V 670 353.3 (277.1; 410.3)a 3.7 (±0.6) 20 (19) 93.2 (69.1; 125.7)
VGSC_R2 L1024V 560 328.2 (260.7; 390.5)a 3.0 (±0.5) 13 (18) 86.5 (63.1; 118.8)
VGSC_R3 L1024V 427 405.4 (329.8; 466.5)a 3.8 (±0.7) 13 (13) 106.9 (79.4; 143.9)
VGSC_R4 A1215D + F1538I 554 508.9 (261.6; 670.8)a 2.6 (±0.6) 16 (12) 125.6 (87.5; 180.3)
VGSC_R5 A1215D + F1538I 435 538.8 (380.6; 670.2)a 3.6 (±0.5) 21 (12) 134.0 (100.4; 176.1)
fluvalinate
Wasatch L1024 479 102.2 (82.7; 118.5) 3.9 (±0.6) 18 (17) —
GH L1024V 118 >5,000a — >45
KOP8 A1215D + F1538 294 92.4 (67.3; 117.5) 4.7 (±1.1) 15 (11) —
TuSB9 A1215D + F1538I 186 >5,000a — — >50
VGSC_C1 L1024 436 83.0 (63.2; 98.5) 3.7 (±0.6) 16 (15) 0.8 (0.6; 1.0)
VGSC_C2 A1215D + F1538 508 87.0 (69.3; 102.4) 3.7 (±0.5) 19 (15) 0.9 (0.8; 1.2)
VGSC_R1 L1024V 188 >5,000a — — >45
VGSC_R2 L1024V 180 >5,000a — — >45
VGSC_R3 L1024V 213 >5,000a — — >45
VGSC_R4 A1215D + F1538I 194 >5,000a — — >50
VGSC_R5 A1215D + F1538I 161 >5,000a — — >50
fenpropathrin
Wasatch L1024 360 21.3 (15.8; 26.9) 3.1 (±0.5) 23 (19) —
GH L1024V 97 >5,000a — — >230
KOP8 A1215D + F1538 297 13.7 (11.0; 16.9) 2.8 (±0.5) 8 (15) —
TuSB9 A1215D + F1538I 182 >5,000a — — >360
VGSC_C1 L1024 476 35.2 (26.2; 44.2)a 2.1 (±0.3) 5 (16) 1.7 (1.2; 2.3)
VGSC_C2 A1215D + F1538 396 21.5 (15.9; 26.8)a 3.5 (±0.5) 15 (19) 1.6 (1.1; 2.2)
VGSC_R1 L1024V 153 >5,000a — — >230
VGSC_R2 L1024V 155 >5,000a — — >230
VGSC_R3 L1024V 180 >5,000a — — >230
VGSC_R4 A1215D + F1538I 171 >5,000a — — >360
VGSC_R5 A1215D + F1538I 156 >5,000a — — >360
Table 2. Toxicity of pyrethroids (bifenthrin, fluvalinate and fenpropathrin) to adult females of backcrossed 
lines VGSC_C1, VGSC_R1-R3 (L1024V genotype), VGSC_C2, VGSC_R4,5 (F1538I + A1215D genotype) and 
their parental strains (Wasatch, GH, KOP8, TuSB9). aNumber of mites used in toxicity tests. bRR compared 
to Wasatch in case of GH, VGSC_C1 and VGSC_R1-3 or KOP8 in case of TuSB9, VGSC_C2 and VGSC_R4,5 
lines. a: Treatment effect was significantly different when compared to Wasatch or KOP8.
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used acaricides. However, to what extent these mutations determine the resistant phenotype is mostly unknown. 
Resistant field strains investigated so far, typically display a broad altered transcriptional response with the puta-
tive involvement of many detoxifying enzymes and transporters that might affect acaricide toxicity52–54. Crossing 
experiments have revealed that a complex genetic make-up typically underlies resistance, implying the additive 
effect of multiple mechanisms35, 55, 56. Moreover, the extent by which resistant alleles confer resistance can also 
vary according to the genetic background in which they are expressed57, 58.
Several studies have used congenic backcrossed lines to assess insecticide related fitness cost/advantage and 
pleiotropic effects59–64. By substituting phenotypic selection with molecular marker-assisted backcrossing, the 
potential accumulation of alleles with additive effect can be uncoupled23. Such a setup has been previously used 
to assess the effects of Aedes aegypti kdr mutations on pyrethroid resistance and its fitness cost24 and recently, to 
investigate resistance levels to METI-I acaricides caused by a mutation in the PSST subunit of complex I in T. 
urticae25.
Here, we analyzed the relative phenotypic contribution of target-site resistance mutations, previously uncov-
ered in highly resistant T. urticae field populations. We adopted a marker-assisted backcrossing procedure 
described in Bajda, et al.25 to untangle the target-site resistance loci from potential complex additive genetic 
mechanisms. Although in this study we cannot exclude a possible effect of closely linked loci65, previous research 
involving resistance gene mapping by means of bulk segregant analysis, revealed a high recombination rate in T. 
urticae38, 39 which makes us believe that the procedure performed here, resulted in near-isogenic lines.
Both abamectin and milbemectin resistance has been reported frequently in spider mite populations world-
wide48, 66, 67 exhibiting >1000 fold resistance in some cases35. These molecules target both GluCls and GABA gated 
chloride channels (GABACl), although GluCls are considered the main target68, 69. In contrast to insects with a 
single copy, the genome of T. urticae harbors six orthologous GluCl genes35. Two non-synonymous mutations 
have been associated with resistance to abamectin, the G314D in GluCl1 and G326E in GluCl335, 36. When G314D 
and G326E were introgressed separately, only low levels of resistance remained. However, when both mutations 
were joined by dedicated crosses, resistance levels increased to 10–20 fold (henceforth, for the schematic visu-
alization of a relative contribution of the mutations in resistance levels, please consult Fig. 5). These resistance 
levels are comparable with a previous study, where an abamectin resistant strain homozygous for both GluCl 
mutations was investigated. Resistance levels in that strain reached only 20-fold36, 70, suggesting that target-site 
mutations were the only factor contributing to resistance. A possible explanation for the relatively low resistance 
levels conferred by the combination of two GluCl mutations may lie in the number of genes involved in channel 
assembly. Glutamate-gated chloride channels typically consist of five subunits, which in T. urticae can be encoded 
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by 5 different GluCl genes. Hence, if the channel consists of a combination of subunits carrying the resistance 
associated substitution (GluCl1 and/or GluCl3) and a GluCl2 subunit (GluCl2 does not carry a resistance asso-
ciated substitution, while GluCl4 and GluCl5 naturally carry substitutions that interfere with abamectin binding 
see Dermauw, et al.35), abamectin binding might still be possible. In addition, we cannot exclude the possibility of 
heteromeric channel assembly, consisting of GluCls and GABACl18, 19. In such case, the existence of mutations in 
GluCl1 and GluCl3 alone would also not be capable to fully prevent channel blocking. Consequently, our results 
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also reconfirm the importance of additional mechanisms in abamectin resistance69, 71, 72. Studies with synergists 
and biochemical tests have previously implied the involvement of detoxification enzymes in resistance in many 
field collected strains worldwide72–74. For instance, a P450 (CYP392A16) was reported to be overexpressed in 
abamectin resistant strains and detoxifies abamectin rapidly71. Therefore very high abamectin resistance levels 
in the MAR-AB strain (Supplementary Table S2) may be attributed to a joint action of P450 detoxification and 
decreased sensitivity of the target-site, potentially even acting synergistically.
Milbemectin belongs to the same insecticidal class as abamectin and acts on the same target-site. Whether 
cross-resistance may occur between both compounds is therefore of crucial importance, and still a matter of 
debate. Here, we show that the combination of both GluCl mutations confers resistance levels of about 10-fold, 
indicating potential cross-resistance risks between milbemectin and abamectin, as has been previously sug-
gested48, 67.
Pyrethroid resistance has been documented globally in T. urticae with resistance levels exceeding 10,000 folds 
in some cases75, 76. Unlike most other arthropods, spider mites have mutations in unique positions on VGSC33, 34, 77, 
instead of the known kdr (L1014F) and super-kdr (M918T) mutations (Musca domestica numbering). The 
super-kdr mutation has been identified only once in a Tetranychus evansi strain78. Three point mutations have 
been located in the sodium channel of spider mites, L1024V and F1538I in combination with A1215D33, 34. 
Backcrossing experiments indicated the major effect of both L1024V and A1215D + F1538I mutations in pyre-
throid resistance (Fig. 5). Interestingly, the KOP8 strain has the A1215D mutation uncoupled from F1538I and is 
susceptible to all pyrethroids, indicating that the mutation alone has no effect on pyrethroid toxicity. So far, the 
mutation F1538I has been studied most thoroughly and its effect in resistance to pyrethroids has been confirmed 
by electrophysiological studies79. Here, we showed that both L1024V and A1215D + F1538I mutations confer 
high resistance levels to all pyrethroid compounds, irrespectively of their type, i.e. presence of α-cyano group 
and/or extended halogenated acidic moiety, suggesting that the sodium channel mutations can cause field failure 
of the pyrethroids.
QoI with acaricidal properties have been introduced for the control of mite infestations relatively recently80, 81. 
Nonetheless, high levels of resistance to bifenazate have already been reported in the field37, 82. Backcrossing 
revealed that the combination of cd1 helix mutations G126S and S141F in cytb confers high levels of bifenaz-
ate resistance. In contrast, the backcrossed lines carrying the P262T substitution, showed LC50 values of 960, 
1,400.6 and 886.1 mg l−1, respectively, while the parental resistant HOL3 was resistant to bifenazate concentra-
tions up to 5,000 mg l−1 (Fig. 5). The backcrossed lines with cd1 helix mutations, showed similar levels of resist-
ance to acequinocyl compared to the parental strain, confirming that acequinocyl cross-resistance is completely 
maternally inherited, and thus linked with the mutation82. One of the possible explanations for the discrepancy 
between bifenazate resistance of the parental strain HOL3 and those of the backcrossed strains is the presence 
of additional resistance mechanisms. Indeed, although a strong correlation between the P262T frequency and 
bifenazate resistance has been reported, to what extent resistance is inherited maternally has only been described 
for acequinocyl82. This is in contrast to cd1 helix mutations, that have been shown to confer resistance levels that 
are completely maternally inherited41, suggesting that no additional mechanisms are involved or needed to attain 
Figure 5. Schematic representation of the relative contribution of target site resistance mutations in overall 
resistance levels to acaricides belonging to different mode of action groups. The size of the circle shape reflects 
the observed levels of resistance (RR vs susceptible parent strain). Only comparisons between the backcrossed 
lines versus its resistant parent are drawn to scale (Table 1).
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very high resistance levels. Another explanation could be that the P262T substitution only confers high resistance 
levels in combination with specific nuclear encoded protein variants that co-evolved with mitochondrial encoded 
cytb mutations, and that uncoupling results in a loss of phenotype.
Resistance to clofentezine and hexythiazox has been frequently reported, and more recently, resistance against 
etoxazole has been also spreading83–85. Insensitivity to etoxazole is thought to be monogenic and recessive84, 85, 
which is in line with target-site resistance as the main mechanism. Screening for I1017F revealed that the muta-
tion has been segregating in populations from different regions of the world for a long period, although etoxazole 
has been only recently used to control spider mites, especially in Europe38. This lead to the hypothesis that the 
mutation was selected by other molecules such as hexythiazox or clofentezine, which was later confirmed in a 
follow-up genetic mapping study39, 86. Here, we provide clear evidence that the I1017F substitution confers very 
high levels of resistance to etoxazole, hexythiazox and clofentezine (Fig. 5). Our results confirm target-site based 
cross-resistance, despite the fact that the three mite growth inhibitors belong to chemically diverse classes87–89. In 
a recent study, Douris, et al.20 found a mutation (I1042M) in CHS1 gene of Plutella xylostella resistant to benzoy-
lureas (BPUs), at the position corresponding to I1017F in T. urticae. Using CRISPR/Cas9 approach coupled with 
homology directed repair (HDR), both the lepidopteran and spider mite mutations (I1056M/F) were introduced 
in the Drosophila CHS1 gene (kkv). Flies carrying either of two mutations were found highly resistant to etoxaz-
ole, but also to a number of BPUs and the hemipteran chitin biosynthesis inhibitor buprofezin. The study, together 
with the results reported here, provide convincing evidence that chitin synthesis inhibitors BPUs, buprofezin and 
mite growth inhibitors, etoxazole, hexythiazox and clofentezin all directly interact with CHS1 and share a similar 
molecular MoA.
Conclusions
Resistance mechanisms in insects and mites can be complex and the relative strength of target-site mutations in 
resistance phenotypes is often not well known. Here, we have used a marker-assisted backcrossing approach to 
look at the phenotypic effect of the main and currently relevant target-site mutations reported to confer resistance 
to abamectin, pyrethroids, mite growth inhibitors and QoI. Mutations in VGSC, CHS and cytb confer high levels 
of resistance and their presence in populations alone is enough to cause field failure after acaricide treatment. 
In contrast, although we confirmed the functional importance of GluCl mutations and the cumulative effect of 
mutations in multiple channels, mutations in only two channels genes does not lead to the high resistance levels 
that have been reported for abamectin resistance. Overall, our results functionally validate the importance of 
mutations that have been inferred from correlation analysis and genetic mapping.
References
 1. Sparks, T. C. & Nauen, R. IRAC: Mode of action classification and insecticide resistance management. Pestic Biochem Physiol. 121, 
122–128 (2015).
 2. Sparks, T. C. Insecticide discovery: An evaluation and analysis. Pestic Biochem Physiol. 107, 8–17 (2013).
 3. Feyereisen, R., Dermauw, W. & Van Leeuwen, T. Genotype to phenotype, the molecular and physiological dimensions of resistance 
in arthropods. Pestic Biochem Physiol. 121, 61–77 (2015).
 4. Van Leeuwen, T. & Dermauw, W. The molecular evolution of xenobiotic metabolism and resistance in chelicerate mites. Annu Rev 
Entomol. 61, 475–498 (2016).
 5. Li, X. C., Schuler, M. A. & Berenbaum, M. R. Molecular mechanisms of metabolic resistance to synthetic and natural xenobiotics. 
Annu Rev Entomol. 52, 231–253 (2007).
 6. Raymond, M., Heckel, D. G. & Scott, J. G. Interactions between pesticide genes - model and experiment. Genetics. 123, 543–551 
(1989).
 7. Bohannan, B. J. M., Travisano, M. & Lenski, R. E. Epistatic interactions can lower the cost of resistance to multiple consumers. 
Evolution 53, 292–295 (1999).
 8. Williams, T. N. et al. Negative epistasis between the malaria-protective effects of alpha(+)-thalassemia and the sickle cell trait. 
Nature Genet. 37, 1253–1257 (2005).
 9. Zhang, Y. X. et al. Synergistic and compensatory effects of two point mutations conferring target-site resistance to fipronil in the 
insect GABA receptor RDL. Sci Rep. 6, doi:10.1038/srep32335 (2016).
 10. Moore, J. H. & Williams, S. M. Traversing the conceptual divide between biological and statistical epistasis: Systems biology and a 
more modern synthesis. Bioessays 27, 637–646 (2005).
 11. Hardstone, M. C. & Scott, J. G. A review of the interactions between multiple insecticide resistance loci. Pest Biochem Physiol. 97, 
123–128 (2010).
 12. Liu, N. N. & Pridgeon, J. W. Metabolic detoxication and the kdr mutation in pyrethroid resistant house flies, Musca domestica (L.). 
Pest Biochem Physiol. 73, 157–163 (2002).
 13. Peyronnet, O., Pichon, Y., Carton, Y. & Delorme, R. Genetic-analysis of deltamethrin resistance in laboratory-selected strains of 
Drosophila melanogaster Meig. Pest Biochem Physiol. 50, 207–218 (1994).
 14. McEnroe, W. D. & Naegele, J. A. The coadaptive process in an organophosphorus-resistant strain of the two-spotted spider mite. 
Tetranychus urticae. Ann Entomol Soc Am. 61, 1055–1059 (1968).
 15. Shi, M. A. et al. Acetylcholinesterase alterations reveal the fitness cost of mutations conferring insecticide resistance. BMC Evol Biol. 
4, doi:10.1186/1471-2148-4-5 (2004).
 16. Georghiou, G. P. Genetics of resistance to insecticide in houseflies and mosquitoes. Exp. Parasitol. 26, 224–255 (1969).
 17. Mckenzie, J. A., Whitten, M. J. & Adena, M. A. The effect of genetic background on the fitness of diazinon resistance genotypes of 
the Australian Sheep Blowfly. Lucilia cuprina. Heredity 49, 1–9 (1982).
 18. Cully, D. F. et al. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371, 
707–711 (1994).
 19. Ludmerer, S. W. et al. Ivermectin and nodulisporic acid receptors in Drosophila melanogaster contain both γ-aminobutyric acid-
gated rdl and glutamate-gated GluClα chloride channel subunits. Biochemistry 41, 6548–6560 (2002).
 20. Douris, V. et al. Resistance mutation conserved between insects and mites unravels the benzoylurea insecticide mode of action on 
chitin biosynthesis. PNAS. 113, 14692–14697 (2016).
 21. Zimmer, C. T. et al. A CRISPR/Cas9 mediated point mutation in the alpha 6 subunit of the nicotinic acetylcholine receptor confers 
resistance to spinosad in Drosophila melanogaster. Insect Biochem Mol Biol. 73, 62–69 (2016).
 22. McCart, C., Buckling, A. & ffrench-Constant, R. H. DDT resistance in flies carries no cost. Curr Biol. 15, R587–R589 (2005).
www.nature.com/scientificreports/
1 1Scientific RePoRTs | 7: 9202  | DOI:10.1038/s41598-017-09054-y
 23. Roush, R. T. & Mckenzie, J. A. Ecological genetics of insecticide and acaricide resistance. Annu Rev Entomol. 32, 361–380 (1987).
 24. Brito, L. P. et al. Assessing the effects of Aedes aegypti kdr mutations on pyrethroid resistance and its fitness cost. Plos One 8, 
doi:10.1371/journal.pone.0060878 (2013).
 25. Bajda, S. et al. A mutation in the PSST homologue of complex I (NADH:ubiquinone oxidoreductase) from Tetranychus urticae is 
associated with resistance to METI acaricides. Insect Biochem Molec. 80, 79–90 (2017).
 26. Jeppson, L. R., Keifer, H. H. & Baker, E. W. Mites injurious to economic plants. (University of California Press, 1975).
 27. Migeon, A. & Dorkeld, F. Spider Mites Web: a comprehensive database for the Tetranychidae, http://www.montpellier.inra.fr/CBGP/
spmweb (2006–2015).
 28. Van Leeuwen, T., Vontas, J., Tsagkarakou, A. & Tirry, L. In Biorational Control of Arthropod Pests: Application and Resistance 
Management (eds Isaac Ishaaya & A. Rami Horowitz) 347–393 (Springer Netherlands, 2009).
 29. Van Leeuwen, T., Dermauw, W., Grbic, M., Tirry, L. & Feyereisen, R. Spider mite control and resistance management: does a genome 
help? Pest Manag Sci 69, 156–159 (2013).
 30. Kramer, T. & Nauen, R. Monitoring of spirodiclofen susceptibility in field populations of European red mites, Panonychus ulmi 
(Koch) (Acari: Tetranychidae), and the cross-resistance pattern of a laboratory-selected strain. Pest Manag Sci 67, 1285–1293 (2011).
 31. Khalighi, M., Tirry, L. & Van Leeuwen, T. Cross-resistance risk of the novel complex II inhibitors cyenopyrafen and cyflumetofen in 
resistant strains of the two-spotted spider mite Tetranychus urticae. Pest Manag Sci 70, 365–368 (2014).
 32. Khajehali, J. et al. Acetylcholinesterase point mutations in European strains of Tetranychus urticae (Acari: Tetranychidae) resistant 
to organophosphates. Pest Manag Sci 66, 220–228 (2010).
 33. Tsagkarakou, A. et al. Identification of pyrethroid resistance associated mutations in the para sodium channel of the two-spotted 
spider mite Tetranychus urticae (Acari: Tetranychidae). Insect Mol Biol. 18, 583–593 (2009).
 34. Kwon, D. H., Clark, J. M. & Lee, S. H. Cloning of a sodium channel gene and identification of mutations putatively associated with 
fenpropathrin resistance in Tetranychus urticae. Pest Biochem Physiol. 97, 93–100 (2010).
 35. Dermauw, W. et al. The cys-loop ligand-gated ion channel gene family of Tetranychus urticae: Implications for acaricide toxicology 
and a novel mutation associated with abamectin resistance. Insect Biochem Molec. 42, 455–465 (2012).
 36. Kwon, D. H., Yoon, K. S., Clark, J. M. & Lee, S. H. A point mutation in a glutamate-gated chloride channel confers abamectin 
resistance in the two-spotted spider mite, Tetranychus urticae Koch. Insect Mol Biol 19, 583–591 (2010).
 37. Van Leeuwen, T. et al. Mitochondrial heteroplasmy and the evolution of insecticide resistance: Non-Mendelian inheritance in 
action. PNAS. 105, 5980–5985 (2008).
 38. Van Leeuwen, T. et al. Population bulk segregant mapping uncovers resistance mutations and the mode of action of a chitin synthesis 
inhibitor in arthropods. PNAS. 109, 4407–4412 (2012).
 39. Demaeght, P. et al. High resolution genetic mapping uncovers chitin synthase-1 as the target-site of the structurally diverse mite 
growth inhibitors clofentezine, hexythiazox and etoxazole in Tetranychus urticae. Insect Biochem Mol Biol. 51, 52–61 (2014).
 40. Chatzivasileiadis, E. A. & Sabelis, M. W. Toxicity of methyl ketones from tomato trichomes to Tetranychus urticae Koch. Exp Appl 
Acarol 21, 473–484 (1997).
 41. Van Leeuwen, T., Tirry, L. & Nauen, R. Complete maternal inheritance of bifenazate resistance in Tetranychus urticae Koch (Acari: 
Tetranychidae) and its implications in mode of action considerations. Insect Biochem Mol Biol. 36, 869–877 (2006).
 42. Navajas, M., Lagnel, J., Fauvel, G. & De Moraes, G. Sequence variation of ribosomal internal transcribed spacers (ITS) in 
commercially important phytoseiidae mites. Exp Appl Acarol 23, 851–859 (1999).
 43. Ilias, A., Vassiliou, V. A., Vontas, J. & Tsagkarakou, A. Molecular diagnostics for detecting pyrethroid and abamectin resistance 
mutations in Tetranychus urticae. Pest Biochem Physiol. 135, 9–14 (2017).
 44. Hall, T. A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids 
Symp Ser. 41, 95–98 (1999).
 45. Van Pottelberge, S., Khajehali, J., Van Leeuwen, T. & Tirry, L. Effects of spirodiclofen on reproduction in a susceptible and resistant 
strain of Tetranychus urticae (Acari: Tetranychidae). Exp Appl Acarol 47, 301–309 (2009).
 46. Van Leeuwen, T., Stillatus, V. & Tirry, L. Genetic analysis and cross-resistance spectrum of a laboratory-selected chlorfenapyr 
resistant strain of two-spotted spider mite (Acari: Tetranychidae). Exp Appl Acarol 32, 249 (2004).
 47. Van Leeuwen, T., Van Pottelberge, S., Nauen, R. & Tirry, L. Organophosphate insecticides and acaricides antagonise bifenazate 
toxicity through esterase inhibition in Tetranychus urticae. Pest Manag Sci 63, 1172–1177 (2007).
 48. Sato, M. E., Da Silva, M. Z., Raga, A. & De Souza, M. F. Abamectin resistance in Tetranychus urticae Koch (Acari: Tetranychidae): 
Selection, cross-resistance and stability of resistance. Neotrop Entomol. 34, 991–998 (2005).
 49. Robertson, J. L. P. H. K. in Pesticide bioassays with arthropods 17–34 (1992).
 50. Robertson, J. L., Russel, R. M., Preisler, H. K. & Savin, N. E. Bioassays in arthropods, 2nd Eds, (Taylor and Francis group LLC, CRC 
press, 2007).
 51. Grbic, M. et al. The genome of Tetranychus urticae reveals herbivorous pest adaptations. Nature 479, 487–492 (2011).
 52. Dermauw, W. et al. A link between host plant adaptation and pesticide resistance in the polyphagous spider mite Tetranychus urticae. 
PNAS. 110, E113–E122 (2013).
 53. Khalighi, M. et al. Molecular analysis of cyenopyrafen resistance in the two-spotted spider mite Tetranychus urticae. Pest Manag Sci 
72, 103–112 (2016).
 54. Demaeght, P. et al. Molecular analysis of resistance to acaricidal spirocyclic tetronic acids in Tetranychus urticae: CYP392E10 
metabolizes spirodiclofen, but not its corresponding enol. Insect Biochem Molec. 43, 544–554 (2013).
 55. Van Pottelberge, S., Van Leeuwen, T., Nauen, R. & Tirry, L. Resistance mechanisms to mitochondrial electron transport inhibitors 
in a field-collected strain of Tetranychus urticae Koch (Acari: Tetranychidae). Bull Entomol Res. 99, 23–31 (2009).
 56. Van Pottelberge, S., Van Leeuwen, T., Khajehali, J. & Tirry, L. Genetic and biochemical analysis of a laboratory-selected spirodiclofen-
resistant strain of Tetranychus urticae Koch (Acari: Tetranychidae). Pest Manag Sci 65, 358–366 (2009).
 57. McKenzie, J. A., Whitten, M. J. & Adena, M. A. The effect of genetic background on the fitness of diazinon resistance genotypes of 
the Australian sheep blowfly, Lucilia cuprina. Heredity 49, 1–9 (1982).
 58. Schrag, S. J., Perrot, V. & Levin, B. R. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc R Soc Lond [Biol]. 
264, 1287–1291 (1997).
 59. Wang, R. & Wu, Y. Dominant fitness costs of abamectin resistance in Plutella xylostella. Pest Manag Sci 70, 1872–1876 (2014).
 60. Yuan, G. et al. Development of near-isogenic lines in a parthenogenetically reproduced thrips species, Frankliniella occidentalis. 
Front Physiol. 8, doi:10.3389/fphys.2017.00130 (2017).
 61. Xiao, Y. et al. A single point mutation resulting in cadherin mislocalization underpins resistance against Bacillus thuringiensis toxin 
in cotton bollworm. J Biol Chem. 292, 2933–2943 (2017).
 62. Helle, W. Genetics of resistance to organophosphorus compounds and its relation to diapause in Tetranychus urticae Koch (Acari). 
(H. Veenman, 1962).
 63. Arnaud, L., Brostaux, Y., Assie, L. K., Gaspar, C. & Haubruge, E. Increased fecundity of malathion-specific resistant beetles in 
absence of insecticide pressure. Heredity 89, 425–429 (2002).
 64. ffrench-Constant, R. H. & Bass, C. Does resistance really carry a fitness cost? Curr Opin Insect Sci. 21, 39–46 (2017).
 65. Hospital, F. Size of donor chromosome segments around introgressed loci and reduction of linkage drag in marker-assisted 
backcross programs. Genetics 158, 1363–1379 (2001).
www.nature.com/scientificreports/
1 2Scientific RePoRTs | 7: 9202  | DOI:10.1038/s41598-017-09054-y
 66. Yorulmaz, S. & Ay, R. Multiple resistance, detoxifying enzyme activity, and inheritance of abamectin resistance in Tetranychus 
urticae Koch (Acarina: Tetranychidae). Turk J Agric For. 33, 393–402 (2009).
 67. Nicastro, R. L., Sato, M. E. & Da Silva, M. Z. Milbemectin resistance in Tetranychus urticae (Acari: Tetranychidae): selection, stability 
and cross-resistance to abamectin. Exp Appl Acarol 50, 231–241 (2010).
 68. Wolstenholme, A. J. Recent progress in understanding the interaction between avermectins and ligand-gated ion channels: putting 
the pests to sleep. Invertebr Neurosci 10, 5–10 (2010).
 69. Clark, J. M., Scott, J. G. & Campos, F. Resistance to avermectins: extent, mechanisms, and management Implications. Annu Rev 
Entomol. 40, 1–30 (1994).
 70. Kwon, D. H., Kang, T. J., Kim, Y. H. & Lee, S. H. Phenotypic- and genotypic-resistance detection for adaptive resistance management 
in Tetranychus urticae Koch. Plos One 10, doi:10.1371/journal.pone.0139934 (2015).
 71. Riga, M. et al. Abamectin is metabolized by CYP392A16, a cytochrome P450 associated with high levels of acaricide resistance in 
Tetranychus urticae. Insect Biochem Molec. 46, 43–53 (2014).
 72. Pavlidi, N. et al. Functional characterization of glutathione S-transferases associated with insecticide resistance in Tetranychus 
urticae. Pestic Biochem Phys 121, 53–60, doi:10.1016/j.pestbp.2015.01.009 (2015).
 73. Campos, F., Krupa, D. A. & Dybas, R. A. Susceptibility of populations of twospotted spider mites (Acari: Tetranychidae) from Florida, 
Holland, and the Canary Islands to abamectin and characterization of abamectin resistance. J Econ Entomol. 89, 594–601 (1996).
 74. Stumpf, N. & Nauen, R. Biochemical markers linked to abamectin resistance in Tetranychus urticae (Acari: Tetranychidae). Pestic 
Biochem Phys 72, 111–121 (2002).
 75. Herron, G. A., Rophail, J. & Wilson, L. J. The development of bifenthrin resistance in two-spotted spider mite (Acari: Tetranychidae) 
from Australian cotton. Exp Appl Acarol 25, 301–310 (2001).
 76. Van Leeuwen, T., Van Pottelberge, S. & Tirry, L. Comparative acaricide susceptibility and detoxifying enzyme activities in field-
collected resistant and susceptible strains of Tetranychus urticae. Pest Manag Sci 61, 499–507 (2005).
 77. Ding, T. B. et al. Molecular characterisation of a sodium channel gene and identification of a Phe1538 to Ile mutation in citrus red 
mite. Panonychus citri. Pest Manag Sci 71, 266–277 (2015).
 78. Nyoni, B. N. et al. Pyrethroid resistance in the tomato red spider mite, Tetranychus evansi, is associated with mutation of the para-
type sodium channel. Pest Manag Sci 67, 891–897 (2011).
 79. Tan, J. G. et al. Identification of amino acid residues in the insect sodium channel critical for pyrethroid binding. Mol Pharmacol 67, 
513–522 (2005).
 80. Dekeyser, M. A. in Proceedings of the BCP Conference, Pests and Diseases. 487–492.
 81. Grosscurt, A. & Avella, L. in Proceedings of the BCP Conference, Crop Science and Technology. 49–56.
 82. Van Nieuwenhuyse, P., Van Leeuwen, T., Khajehali, J., Vanholme, B. & Tirry, L. Mutations in the mitochondrial cytochrome b of 
Tetranychus urticae Koch (Acari: Tetranychidae) confer cross-resistance between bifenazate and acequinocyl. Pest Manag Sci 65, 
404–412 (2009).
 83. Herron, G., Edge, V. & Rophail, J. Clofentezine and hexythiazox resistance in Tetranychus urticae Koch in Australia. Exp Appl Acarol 
17, 433–440 (1993).
 84. Uesugi, R., Goka, K. & Osakabe, M. H. Genetic basis of resistances to chlorfenapyr and etoxazole in the two-spotted spider mite 
(Acari: Tetranychidae). J Econ Entomol. 95, 1267–1274 (2002).
 85. Kobayashi, M., Kobayashi, S. & Nishimori, T. Occurrence of etoxazole resistance individuals of the two-spotted spider mite, 
Tetranychus urticae Koch from a limited region. Jpn J Appl Entomol Z. 45, 83–88 (2001).
 86. Asahara, M., Uesugi, R. & Osakabe, M. Linkage between one of the polygenic hexythiazox resistance genes and an etoxazole 
resistance gene in the twospotted spider mite (Acari: Tetranychidae). J. Econ Entomol. 101, 1704–1710 (2008).
 87. Ishida, T., Suzuki, J., Tsukidate, Y. & Mori, Y. in BCP Crop protection conference pests and pests diseases Vol. 1 37–44 (Brighton, UK, 1994).
 88. Yamada, T., Kaeriyama, M., Matsui, N. & Yoneda, H. Development of a new miticide, hexythiazox. J Pestic Sci. 12, 327–335 (1987).
 89. Aveyard, C. S., Peregrine, D. J. & Bryan, K. M. G. Biological activity of clofentezine against egg and motile stages of tetranychid mites. 
Exp Appl Acarol 2, 223–229 (1986).
Acknowledgements
This project was supported by the Research Foundation Flanders (FWO) (grant G009312N to L.T. and T.V.L. and grant 
G053815N to L.T., T.V.L. and W.D.). W.D is a postdoctoral fellow of the Research Foundation Flanders. Part of this 
research has been co-financed by Greek national funds through the Operational Program “Education and Lifelong 
Learning” of the National Strategic Reference Framework (NSRF) Research Funding Program: THALES (projects 
377301 and 380264). Authors thank Nicky Wybouw for help in performing toxicity test and manuscript proofreading 
and Naciye Sena Cagatay for her contribution in toxicity assays. Authors also thank Prof dr. Richard M. Clark for kindly 
providing T. urticae strains Wasatch and GH and dr. Juan M. Alba Cano for providing the KOP8 strain.
Author Contributions
T.V.L., M.R., S.B. designed research. M.R. and S.B. performed the experiments with contribution of S.P., C.T. and 
M.P. M.R. and S.B. analyzed data. S.B., M.R. and T.V.L. wrote the manuscript, with input from W.D. and J.V. All 
authors read and approved the final manuscript.
Additional Information
Supplementary information accompanies this paper at doi:10.1038/s41598-017-09054-y
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
Reproduced with permission of copyright owner. Further reproduction
prohibited without permission.
